City of Industry, CA -- (SBWIRE) -- 07/02/2018 -- This report studies the global Home Use Lancing Devices market status and forecast, categorizes the global Home Use Lancing Devices market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.

The lancing device is a convenient medical tool for collecting capillary blood samples for glucose monitoring or other tests requiring one or two drops of blood. It is dedicated for home diagnostics and aimed to be used by patients when performing skin puncture on them. A convenient and effortless device specially designed for the highest comfort in daily diabetes management.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/233002/global-home-use-lancing-devices-market

In the last several years, global market of Lancing device developed year by year, with an average growth rate of 5.5% for the sales. In 2016, global revenue of lancing device is nearly 270 M USD; the sale is about 47.2 million units.

In the next few years, Lancing device industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.

The classification of Lancing device includes Adjustable Lancing Device, Non-adjustable Lancing Device. The proportion of Adjustable Lancing Device in 2016 is about 94%, and the proportion is increasing trend from 2012 to 2016.

Lancing device is widely used in cholesterol tests, glucose tests and other tests. The more than half of lancing device is used in glucose test, and the sales proportion in 2016 is about 70%, but the Lancing device used in cholesterol test is enjoying more and more market share.

North America and Europe is the main consumption places, with a consumption market share nearly 41.7% and 27.6% in 2016. Other regions also enjoy the major market share in global region.

Market competition is intense. Roche, LifeScan, Abbott, Ascensia, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. With the development of society and the changing of consumer demand, the Lancing device industry will be more and more popular in the future.

The global Home Use Lancing Devices market is valued at 270 million US$ in 2017 and will reach 410 million US$ by the end of 2025, growing at a CAGR of 5.4% during 2018-2025.

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/233002/global-home-use-lancing-devices-market

The major manufacturers covered in this report

Roche

LifeScan

Abbott

Ascensia

B. Braun

Terumo

ARKRAY

Trividia Health

SANNUO

GMMC

BIONIME

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America

Europe

China

Japan

Southeast Asia

India

About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.